Stagflation Stocks
How to Invest During Stagflation.
Thu, Jul 10th, 2025
In a stagflationary environment - marked by high inflation, sluggish economic growth, and rising costs - certain sectors tend to demonstrate resilience and outperformance. This guide on how to invest for stagflation focuses on companies with strong pricing power, stable cash flows, and defensive business models, prioritizing stocks with historically reasonable price/earnings (P/E) ratios below 30 times trailing earnings to avoid overvalued plays. Key sectors include energy and commodities, which benefit from rising prices; consumer staples and healthcare, which provide essential goods and services; and real estate investment trusts (REITs), which offer inflation-adjusted rental income. Utilities stand out for their pricing stability and steady demand, while insurance companies and select financial services firms profit from higher interest rates and inflation-linked pricing. By focusing on fundamentally strong, inflation-resistant companies, this list of "stagflation stocks" provides a strategic approach to navigating stagflation-driven market conditions.
News for Stagflation Stocks
Analysts remain bullish on Constellation Brands, citing its premium brand focus and reliable dividend as reasons to buy the beaten-down stock.
X CEO Linda Yaccarino said she’s stepping down after two years running Elon Musk’s social media platform
The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +0.61%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.72%. September E-mini...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.28%. September E-mini S&P futures (ESU25...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.66%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.83%. September E-mini S&P futures (ESU25...
Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an approximately $10 billion deal